You describe the "what if" which is why we're here in the first place.
So, what if Innovus makes it to cash positive with 0 debt in the very near term and all the convertibles are gone.
So, what if Fluticare clears the FDA in the next few months, having already been proven to be better than Flonase and exceeds Flonase sales by how much?
So, what if Innovus continues to expand their global market area even further than its already impressive coverage.
More product is good, but good products are what counts. It's not all about fluticare being cleared for otc but it would certainly give a boost to the bottom line.